{"hq_id":"hq-p-chd-000090","name":"Children's Fluoride Supplement Drops / Chewable Tablets","category":{"primary":"children","secondary":"oral_care","tags":["fluoride supplement","drops","tablets","children","systemic fluoride"]},"product_tier":"CHD","overall_risk_level":"high","description":"Prescription and OTC fluoride supplement drops (for infants 6 months+) and chewable tablets (for children 3+) intended for areas without fluoridated water. These deliver systemic fluoride (0.25-1.0 mg/dose) absorbed through the GI tract — a fundamentally different exposure pathway than topical fluoride. Systemic fluoride's efficacy for caries prevention is now considered inferior to topical application, yet supplements persist in practice guidelines. Cumulative fluoride from supplements + toothpaste + foods/beverages + water creates complex dosimetry that is rarely calculated per-child. Overdose risk is significant with tablet formulations attractive to children.","synthesis":{"derived_risk_level":"moderate","synthesis_confidence":0.86,"synthesis_method":"compound_composition","context_used":"human_infant","context_source":"product_users","exposure_modifier":1.208,"vulnerability_escalated":true,"escalation_reason":"CHD tier product","compounds_resolved":4,"compounds_total":4,"synthesis_date":"2026-03-27","synthesis_version":"1.0.0"},"hazard_summary":{"sensitive_populations":"infants, children","overall_risk":"high","primary_concerns":["Systemic fluoride accumulates in bone and developing teeth — dental fluorosis risk is 2-4x higher with supplement use; narrow therapeutic window; accidental overdose of flavored tablets can cause acute toxicity (nausea, vomiting, cardiac arrhythmia)"],"exposure_routes":"100% systemic absorption through gastrointestinal tract; Daily cumulative dosing (0.25-1.0 mg/day for months to years); Accidental overdose risk from palatable chewable tablets"},"exposure":{"users":["infant","child"],"routes":["dermal"],"contact_types":["skin_prolonged"],"duration":"hours","frequency":"daily","scenarios":["Dermal contact during handling of Children's Fluoride Supplement Drops / Chewable Tablets (hours contact)","Incidental mouthing or hand-to-mouth transfer by children"],"notes":"Exposure to Children's Fluoride Supplement Drops / Chewable Tablets occurs via dermal. Children and infants face higher exposure per body weight due to developing detoxification systems, higher surface-area-to-weight ratio, and behavioral factors (mouthing, crawling)."},"consumer_guidance":{"usage_warning":"Fluoride supplements provide systemic fluoride, which is now considered less effective than topical fluoride for cavity prevention. They significantly increase dental fluorosis risk. Discuss with your pediatrician whether topical-only approaches (varnish, toothpaste) are sufficient.","safer_alternatives":["Topical fluoride only (toothpaste + professional varnish)","Hydroxyapatite toothpaste (remineralizing, no fluoride)","Xylitol supplements (cavity prevention through bacterial pathway)","Dietary counseling to reduce sugar/acid exposure"]},"regulatory":{"applicable_regulations":[{"jurisdiction":"USA","regulation":"Consumer Product Safety Improvement Act (CPSIA) 2008","citation":"15 U.S.C. 2051-2089","requirements":"Lead content limited to 100 ppm in children's products. Six phthalates permanently banned (DEHP, DBP, BBP, DINP, DIBP, DPENP) in children's toys and child care articles. Third-party testing and certification required.","compliance_status":null,"effective_date":"2008-08-14","enforcing_agency":"CPSC","penalties":null,"source_ref":null},{"jurisdiction":"USA","regulation":"16 CFR Part 1501 — Small Parts Regulation","citation":"16 CFR 1501","requirements":"Products intended for children under 3 must not contain small parts that pose choking hazards.","compliance_status":null,"effective_date":null,"enforcing_agency":"CPSC","penalties":null,"source_ref":null},{"jurisdiction":"EU","regulation":"Toy Safety Directive 2009/48/EC","citation":"Directive 2009/48/EC","requirements":"EN 71 compliance required. Migration limits for 19 elements. CMR substance restrictions. REACH SVHC reporting for >0.1% w/w.","compliance_status":null,"effective_date":"2011-07-20","enforcing_agency":null,"penalties":null,"source_ref":null},{"jurisdiction":"USA -- California","regulation":"California Proposition 65","citation":"CA Health & Safety Code 25249.5-25249.13","requirements":"Products containing listed chemicals above safe harbor levels require clear and reasonable warnings.","compliance_status":null,"effective_date":null,"enforcing_agency":"OEHHA","penalties":null,"source_ref":null}],"certifications":[{"name":"CPSIA","issuer":"CPSC","standard":"Consumer Product Safety Improvement Act","scope":"Lead, phthalate content limits for children's products"},{"name":"ASTM F963","issuer":"ASTM International","standard":"Standard Consumer Safety Specification for Toy Safety","scope":"Mechanical, flammability, chemical hazards"},{"name":"EN 71","issuer":"CEN","standard":"Safety of Toys (Parts 1-13)","scope":"EU toy safety directive covering mechanical, flammability, chemical migration"}],"labeling":{"required_disclosures":[],"prop65_warning":{"required":null,"chemicals":[],"endpoint":null,"notes":null},"ghs_labeling":{"required":null,"signal_word":null,"pictograms":[],"hazard_statements":[],"notes":null},"hidden_ingredients":{"trade_secret_protected":null,"categories_hidden":[],"estimated_count":null,"known_concerns":null,"notes":null},"notes":null},"recalls":[],"regulatory_gap":null,"notes":null},"lifecycle":{"recyclable":false,"disposal_guidance":"Donate if reusable; check local recycling for hard plastics; landfill for worn items","hazardous_waste":false,"expected_lifespan":"1-3_years"},"formulation":{"form":"oral drops / chewable tablet","key_ingredients":["Sodium fluoride (systemic)","Sorbitol vehicle"],"certifications":[]},"materials":{"common":[],"concerning":[],"preferred":[]},"compound_composition":[{"hq_id":"hq-c-ino-000022","compound_name":"Fluoride (sodium fluoride)","role":"Active systemic fluoride agent","typical_concentration":"0.25-1.0 mg F⁻/dose"},{"hq_id":"hq-c-org-000533","compound_name":"Sorbitol (E420)","role":"Sweetener/vehicle (sorbitol)","typical_concentration":"40-60%"},{"hq_id":"hq-c-org-000190","compound_name":"Saccharin","role":"Sweetener (saccharin)","typical_concentration":"0.1%"},{"hq_id":"hq-c-org-000087","compound_name":"Methylparaben","role":"Preservative","typical_concentration":"0.1%"}],"identifiers":{"common_names":["children's fluoride supplement drops / chewable tablets"],"aliases":[],"manufacturer":null,"brands":[]},"brand_examples":[{"brand":"Luride Drops (0.125 mg F/drop)","manufacturer":"Unknown","market_position":"mass_market","notable":""},{"brand":"Fluoriguard Chewable Tablets","manufacturer":"Unknown","market_position":"mass_market","notable":""},{"brand":"Pediaflor Drops","manufacturer":"Unknown","market_position":"mass_market","notable":""}],"sources":[{"type":"expert_curation","name":"ALETHEIA Safety Database","date":"2026-03-23"},{"type":"regulation","title":"Consumer Product Safety Improvement Act (CPSIA) 2008 (15 U.S.C. 2051-2089)","jurisdiction":"USA","year":2008,"citation":"15 U.S.C. 2051-2089","id":"src_9d01b546"},{"type":"regulation","title":"16 CFR Part 1501 — Small Parts Regulation (16 CFR 1501)","jurisdiction":"USA","citation":"16 CFR 1501","id":"src_3e241b80"},{"type":"regulation","title":"Toy Safety Directive 2009/48/EC","jurisdiction":"EU","year":2011,"citation":"Directive 2009/48/EC","id":"src_6c59b098"},{"type":"regulation","title":"California Proposition 65 (CA Health & Safety Code 25249.5-25249.13)","jurisdiction":"USA -- California","citation":"CA Health & Safety Code 25249.5-25249.13","id":"src_fe1d5adc"},{"id":"usphs_water_fluoridation_2015","type":"regulatory","title":"US Public Health Service Recommendation for Fluoride Concentration in Drinking Water — Updated 2015 (0.7 mg/L)","year":2015,"inherited_from_compound":"hq-c-ino-000022"},{"id":"epa_fluoride_drinking_water","type":"regulatory","title":"US EPA: Fluoride in Drinking Water — Maximum Contaminant Level (4 mg/L), Secondary MCL (2 mg/L), and Health Effects Review","year":2016,"inherited_from_compound":"hq-c-ino-000022"},{"id":"fda_efsa_sorbitol_2020","type":"regulatory","title":"FDA GRAS 21 CFR 184.1835 Sorbitol; EFSA E420 Re-evaluation 2019 ADI Not Specified; JECFA ADI Not Specified; Osmotic Laxative >50g/day; Contraindicated Hereditary Fructose Intolerance HFI Aldolase B; Hepatic Sorbitol Dehydrogenase Fructose Conversion; Toddler Diarrhea Apple Pear Juice Natural Sorbitol; 70% Solution Pharmaceutical Laxative; No IARC NTP EPA EFSA Carcinogenicity Classification","year":2020,"inherited_from_compound":"hq-c-org-000533"},{"id":"fda_saccharin_gras_2010","type":"regulatory","title":"US FDA: Saccharin — GRAS Affirmation (2010), History of Proposed Bans, NTP Delisting (2000), ADI 5 mg/kg bw/day, and Current Regulatory Status in US Food Supply (2022)","year":2022,"inherited_from_compound":"hq-c-org-000190"},{"id":"ntp_saccharin_delisting_2000","type":"regulatory","title":"US National Toxicology Program: Saccharin Removal from Report on Carcinogens (2000) — Rat Bladder Mechanism Human Non-Relevance, Extensive Human Epidemiology Data, and Prop 65 Delisting (2001)","year":2000,"inherited_from_compound":"hq-c-org-000190"},{"id":"eu_sccs_parabens_2021","type":"regulatory","title":"EU Scientific Committee on Consumer Safety (SCCS): Opinion on Parabens (Methylparaben, Ethylparaben, Propylparaben, Butylparaben) in Cosmetics","year":2021,"inherited_from_compound":"hq-c-org-000087"},{"id":"iarc_3_methylparaben","type":"regulatory","title":"IARC Monographs Volume 101: Methylparaben — Group 3 Evaluation (Not Classifiable as to Carcinogenicity in Humans)","year":2013,"inherited_from_compound":"hq-c-org-000087"}],"meta":{"schema_version":"4.0.0","last_updated":"2026-03-25","timestamp":"2026-05-01T19:54:44.087Z"}}